Cardio-Pulmonary diseases are common

Diseases of the heart and the lung are the leading cause of death in the world. Of all diseases, cardio-pulmonary disorders have the highest socioeconomic burden worldwide. The rate of cardio-pulmonary diseases increases with the age. Thus, in an aging population, the frequency of these diseases rises.


The Problem: Cardio-Pulmonary diseases are changing

The therapy of cardio-pulmonary diseases has seen much progress in recent years. For example, whereas the early phase of a severe heart failure was usually not survived in the past, the current treatments has much improved the early outcome. This progress, however, came with a price: The rate of chronic congestive heart failure has increased. As this disease is in large parts a consequence of a mal-adaptive remodeling process, novel therapies are needed to prevent this deleterious adaptive process.

June 2017-Symposium "New Perspectives in Cardio-Pulmonary Research"

ECCPS – a multi-disciplinary centre to combat cardio-pulmonary diseases

Within the ECCPS researchers from the universities of Giessen und Frankfurt and of the Max-Planck-Institute (MPI) for Heart- and Lung-Research in Bad Nauheim have joined forces. The ECCPS brings together basic scientists, clinicians and clinical-scientists of numerous disciplines. The Cluster aims at translational research. Our interdisciplinary team allows us to study mechanisms of cardio-pulmonary diseases in model systems ranging from cell culture experiments to animal models and to combine these results with clinical data. Importantly, we are well equipped to carry out translational studies validating our basic research results in patients in the clinical setting. Moreover, physician-scientists of the ECCPS are intensely involved in clinical studies at every stage to evaluate novel therapeutics and therapies.

ECCPS – our mission

Collectively, the ECCPS is a DFG-funded centre of excellence. By exploiting translational research, the Excellence Cluster combats cardio-pulmonary diseases.